- Consultation Document
- Invasive aspergillosis
- Neutropenia
- Allogeneic bone marrow transplantation
- Liver transplantation
- Kidney transplantation
- Heart transplantation
- Burns and Aspergillosis
- Chronic granulomatous disease
- Neonatal aspergillosis
- Non or mildly immunocompromised patient
- Pediatric aspergillosis
- Lung transplantation
- Post-operative aspergillosis
- Treatment of particular organs:
- Airways (tracheobronchial)
- Epiglottis and laryngeal aspergillosis
- Bronchial stump aspergillosis
- Aspergillus empyema
- Aspergillus endocarditis
- Aspergillus pericarditis
- Vascular graft infection with Aspergillus
- Osteomyelitis
- Invasive external otitis
- Oral aspergillosis
- Aspergillus thyroiditis - Updated May 2008
- Oesophageal aspergillosis - Updated April 2008
- Gastric and colonic aspergillosis
- Peritonitis in the context of CAPD
- Renal aspergillosis
- Sinuses
- Central nervous system
- Invasive Pulmonary Aspergillosis
- Aspergillosis in AIDS
- Treatment of specific noninvasive Aspergillus diseases
- Antifungal drug Summaries of Product Characteristics (SPC's)
- New drugs for aspergillosis
- Side effects of anti-fungal drugs (images)
- In vitro susceptibility testing results
- Intracavitary amphotericin B
- Management algorithms
